Traws Pharma, Inc.TRAWNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.25
↑ 76% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-1.04
Historical baseline
PeriodValueYoY Change
2024-0.25+69.6%
2023-0.83-15.9%
2022-0.72+73.0%
2021-2.66+18.3%
2020-3.25-1179.1%
2019-0.25+39.9%
2018-0.42+24.5%
2017-0.56-9.7%
2016-0.51+43.9%
2015-0.91-